Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection

Real-world results of nivolumab monotherapy against HCC are lacking in the hepatitis B virus (HBV)-endemic, Asia-Pacific regions. Moreover, heterogeneous responses to immune checkpoint inhibitors have rarely been described in advanced HCC. The aim of this study is to evaluate the efficacy and safety...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Oncol
Main Authors: Sung, Pil Soo, Jang, Jeong Won, Lee, Jaejun, Lee, Soon Kyu, Lee, Hae Lim, Yang, Hyun, Nam, Hee Chul, Lee, Sung Won, Bae, Si Hyun, Choi, Jong Young, Han, Nam Ik, Yoon, Seung Kew
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7338665/
https://ncbi.nlm.nih.gov/pubmed/32695681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01043
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki